IP Library Granted Patent US 12,371,457
Granted Patent B2
US 12,371,457 · App. 16/415,187 · Granted Jul 29, 2025

Protein expression strains

Inventors: Christopher John Arthur Finnis (Nottingham, GB); Jennifer Mary Mclaughlan (Nottingham, GB); Per Kristoffer Nordeide (Copenhagen, DK); Preethi Ramaiya (Sunnyvale, CA)
Assignee: Sartorius Albumedix Limited
C07K14/395C07K1/14C12N1/14C12N1/185C12N9/104C12N9/93C12N15/04C12N15/63C12N15/80C12N15/81C12P21/02C12Y603/02019C12R2001/865
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,371,457
App. No.
16/415,187
Granted
Jul 29, 2025
Kind
B2
Abstract

The invention provides an improved host strain for production of desired protein.

Claims (41)

1. A fungal host cell comprising a modified NOT4 gene, wherein the Not4 protein encoded by the modified NOT4 gene comprises a mutation at a position corresponding to a position selected from the group consisting of: 429, 430, 434, and 437 of SEQ ID NO: 2, which results in:

a. a reduced level of expression of Not4 protein,

b. a reduced activity level of Not4 protein, or

c. a reduced level of expression of NOT4 gene

wherein the reduced level is relative to that of a wild-type Not4 protein or NOT4 gene of a reference fungal host cell,

wherein each of said fungal host cell and said reference fungal host cell is Saccharomyces cerevisiae,

wherein each of said fungal host cell and said reference fungal host cell comprises a nucleotide sequence encoding a heterologous protein which is an albumin or a fusion thereof,

wherein the heterologous protein has a higher yield in the fungal host cell than in the reference fungal host cell.

2. The fungal host cell of claim 1 , wherein the reference fungal host cell has a Not4 protein that comprises or consists of SEQ ID NO: 2.

3. The fungal host cell according to claim 1 in which the Not4 protein encoded by the modified NOT4 gene comprises a substitution from F to I at a position corresponding to position 429 of SEQ ID NO: 2.

4. The fungal host cell according to claim 3 , comprising a polynucleotide encoding SEQ ID NO: 4.

5. A method for producing a heterologous protein which is an albumin or fusion thereof from a fungal host cell comprising:

(i) providing a fungal host cell according to claim 1 , and

(ii) culturing the fungal host cell or culture to produce the desired protein.

6. A method for increasing the yield of a heterologous protein which is an albumin or fusion thereof comprising:

(i) providing a fungal host cell according to claim 1 , and

(ii) culturing the fungal host cell to produce the desired protein.

7. The method according to claim 5 in which the yield of the heterologous protein is at least 2% higher than the yield from a reference fungal host cell having the Not4 protein of SEQ ID NO: 2.

8. The method according to claim 5 in which the fungal host cell is cultured at a scale of at least 5 L.

9. The method according to claim 6 in which the yield of the heterologous protein is at least 2% higher than the yield from a reference fungal host cell having a Not4 protein of SEQ ID NO: 2.

10. The method according to claim 6 in which the fungal host cell is cultured at a scale of at least 5 L.

11. The method according to claim 5 , wherein the method further comprises:

(iii) recovering the heterologous protein,

(iv) purifying the heterologous protein,

(v) formulating the heterologous protein with a therapeutically acceptable carrier or diluent thereby to produce a therapeutic product suitable for administration to a human or an animal, and/or

(vi) providing the heterologous protein in unit dosage form.

12. The method according to claim 6 , wherein the method further comprises:

(iii) recovering the heterologous protein,

(iv) purifying the heterologous protein,

(v) formulating the heterologous protein with a therapeutically acceptable carrier or diluent thereby to produce a therapeutic product suitable for administration to a human or an animal, and/or

(vi) providing the heterologous protein in unit dosage form.

13. A method for producing a heterologous protein which is an albumin or fusion thereof from a fungal host cell comprising:

(i) providing a fungal host cell according to claim 3 , and

(ii) culturing the fungal host cell or culture to produce the heterologous protein.

14. The method according to claim 13 in which the yield of the heterologous protein is at least 2% higher than the yield from a reference fungal host cell having a Not4 protein of SEQ ID NO: 2.

15. The method according to claim 13 in which the fungal host cell is cultured at a scale of at least 5 L.

16. A method for producing a heterologous protein which is an albumin or fusion thereof from a fungal host cell comprising:

(i) providing a fungal host cell according to claim 4 , and

(ii) culturing the fungal host cell or culture to produce the heterologous protein.

17. The method according to claim 16 in which the yield of the heterologous protein is at least 2% higher than the yield from a reference fungal host cell having a Not4 protein of SEQ ID NO: 2.

18. The method according to claim 16 in which the fungal host cell is cultured at a scale of at least 5 L.

Assignments (5)
CHANGE OF NAME Recorded Mar 11, 2025
From: ALBUMEDIX LTD
To: SARTORIUS ALBUMEDIX LIMITED
Reel/Frame 070468/0573 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2022
From: ALBUMEDIX A/S
To: ALBUMEDIX LTD.
Reel/Frame 060791/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2022
From: FINNIS, CHRISTOPHER JOHN ARTHUR; MCLAUGHLAN, JENNIFER MARY; NORDEIDE, PER KRISTOFFER
To: ALBUMEDIX A/S
Reel/Frame 060746/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2022
From: NOVOZYMES A/S
To: ALBUMEDIX A/S
Reel/Frame 060746/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2022
From: RAMAIYA, PREETHI
To: NOVOZYMES A/S
Reel/Frame 061116/0673 →
Priority Claims (1)
EP 16152977 · Jan 27, 2016 · regional
Continuity (5)
Continuation 15593549 · May 12, 2017
Continuation PCTUS2016068239 · Dec 22, 2016
Provisional Application 62278728 · Jan 14, 2016
Provisional Application 62270762 · Dec 22, 2015
Related Publication 20200157155A1 · May 21, 2020
References Cited (199)
US 4302386A · Stevens · 1981 [cited by applicant]
US 5223409A · Ladner et al. · 1993 [cited by applicant]
US 5728553A · Goodey et al. · 1998 [cited by applicant]
US 5827693A · De Angelo et al. · 1998 [cited by applicant]
US 6159705A · Trueheart et al. · 2000 [cited by applicant]
US 10023618B2 · Finnis et al. · 2018 [cited by applicant]
US 11130979B2 · Finnis et al. · 2021 [cited by applicant]
US 11396670B2 · Finnis et al. · 2022 [cited by applicant]
US 20040171154A1 · Storici et al. · 2004 [cited by applicant]
US 20110287143A1 · Gysler et al. · 2011 [cited by applicant]
US 20180009856A1 · Finnis et al. · 2018 [cited by applicant]
CN 102123615A · 2011 [cited by applicant]
CN 102296033A · 2011 [cited by applicant]
EP 0319067A1 · 1989 [cited by applicant]
EP 399455A2 · 1990 [cited by applicant]
EP 428141A2 · 1991 [cited by applicant]
EP 0464590A2 · 1992 [cited by applicant]
FR 2980483A1 · 2013 [cited by applicant]
JP 2001501097A · 2001 [cited by applicant]
JP 2010029148A · 2010 [cited by applicant]
JP 2011103789A · 2011 [cited by applicant]
WO WO199001063A1 · 1990 [cited by applicant]
WO WO199204367A1 · 1992 [cited by applicant]
WO WO199206204A1 · 1992 [cited by applicant]
WO WO1992013951A1 · 1992 [cited by applicant]
WO WO199517413A1 · 1995 [cited by applicant]
WO WO199522625A1 · 1995 [cited by applicant]
WO WO1996000787A1 · 1996 [cited by applicant]
WO WO199637515A1 · 1996 [cited by applicant]
WO WO1998013513A2 · 1998 [cited by applicant]
WO WO200024883A1 · 2000 [cited by applicant]
WO WO200044772A2 · 2000 [cited by applicant]
WO WO2000056900A2 · 2000 [cited by applicant]
WO WO2003066824A2 · 2003 [cited by applicant]
WO WO2004009819A2 · 2004 [cited by applicant]
WO WO2005061718A1 · 2005 [cited by applicant]
WO WO2006066595A2 · 2006 [cited by applicant]
WO WO2006067511A1 · 2006 [cited by applicant]
WO WO2006136831A2 · 2006 [cited by applicant]
WO WO2009126920A2 · 2009 [cited by applicant]
WO WO2010059315A1 · 2010 [cited by applicant]
WO WO2010092135A2 · 2010 [cited by applicant]
WO WO2010128142A1 · 2010 [cited by applicant]
WO WO2011051489A2 · 2011 [cited by applicant]
WO WO2011103076A1 · 2011 [cited by applicant]
WO WO2011124718A1 · 2011 [cited by applicant]
WO WO2012059486A1 · 2012 [cited by applicant]
WO WO2012112188A1 · 2012 [cited by applicant]
WO WO2012150319A1 · 2012 [cited by applicant]
WO WO2013075066A2 · 2013 [cited by applicant]
WO WO2013135896A1 · 2013 [cited by applicant]
WO WO2014031831A1 · 2014 [cited by applicant]
WO WO2014072481A1 · 2014 [cited by applicant]
WO WO2014138371A1 · 2014 [cited by applicant]
WO WO2014179657A1 · 2014 [cited by applicant]
WO WO2015036579A1 · 2015 [cited by applicant]
WO WO2015063611A2 · 2015 [cited by applicant]
WO WO2017112847A1 · 2017 [cited by applicant]
Preissler et al (The EMBO Journal, vol. 34, No. 14, 2015, pp. 1905-1924). (Year: 2015). [cited by examiner]
Kerry-Williams (Yeast, 1998, vol. 14, pp. 161-169). (Year: 1998). [cited by examiner]
Bork (Genome Research, 10:348-400, 2000) (Year: 2000). [cited by examiner]
Smith et al (Nature Biotechnology 15:1222-1223, 1997) (Year: 1997). [cited by examiner]
Brenner (TIG 15:132-133, 1999) (Year: 1999). [cited by examiner]
Broun et al. (Science 282:1315-1317, 1998) (Year: 1998). [cited by examiner]
Van de Loo et al. (Proc. Natl. Acad. Sci. 92:6743-6747, 1995). (Year: 1995). [cited by examiner]
Ayer et al,. The critical role of glutathione in maintenance of the mitochondrial genome. Free Radic Biol Med. Dec. 15, 2010;49(12):1956-68. [cited by applicant]
Azzouz et al., Specific roles for the Ccr4-Not complex subunits in expression of the genome. RNA. Mar. 2009;15(3):377-83. [cited by applicant]
Bai et al., The CCR4 and CAF1 proteins of the CCR4-NOT complex are physically and functionally separated from NOT2, NOT4, and NOT5. Mol Cell Biol. Oct. 1999;19(10):6642-51. [cited by applicant]
Bakti et al., Study on the glutathione metabolism of the filamentous fungus Aspergillus nidulans. Acta Microbiol Immunol Hung. Sep. 1, 2017;64(3):255-272. [cited by applicant]
Barton et al., Site-directed, recombination-mediated mutagenesis of a complex gene locus. Nucleic Acids Res. Dec. 25, 1990;18(24):7349-55. [cited by applicant]
Berndsen et al., New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. Apr. 2014;21(4):301-7. [cited by applicant]
Bhaskar et al., Architecture of the ubiquitylation module of the yeast Ccr4-Not complex. Structure. May 5, 2015;23(5):921-8. [cited by applicant]
Biterova et al., Mechanistic details of glutathione biosynthesis revealed by crystal structures of [cited by applicant]
Biterova et al., Structural basis for feedback and pharmacological inhibition of [cited by applicant]
Blessing, The role of Not4 in cellular homeostasis during proliferation and differentiation in [cited by applicant]
Bowie et al., Identifying determinants of folding and activity for a protein of unknown structure. Proc Natl Acad Sci U S A. Apr. 1989;86(7):2152-6. [cited by applicant]
Calissano et al., In vivo site-directed mutagenesis of Neurospora crassa beta-tubulin gene by spheroplasts transformation with oligonucleotides. Fungal Genetics Reports. 1996;43:1-3. [cited by applicant]
Collart et al., NOT1(CDC39), NOT2(CDC36), NOT3, and NOT4 encode a global-negative regulator of transcription that differentially affects TATA-element utilization. Genes Dev. Mar. 1, 1994;8(5):525-37. [cited by applicant]
Collart et al., The Ccr4—not complex. Gene. Jan. 15, 2012;492(1):42-53. [cited by applicant]
Collart, Global control of gene expression in yeast by the Ccr4-Not complex. Gene. Aug. 14, 2003;313:1-16. [cited by applicant]
Cullen et al., Sequence and centromere proximal location of a transformation enhancing fragment ans 1 from Aspergillus nidulans. Nucleic Acids Res. Nov. 25, 1987;15(22):9163-75. [cited by applicant]
Derbyshire et al., A simple and efficient procedure for saturation mutagenesis using mixed oligodeoxynucleotides. Gene. 1986;46(2-3):145-52. [cited by applicant]
Dockal et al., The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. Oct. 8, 1999;274(41):29303-10. [cited by applicant]
Dominguez et al., Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches. Structure. Apr. 2004;12(4):633-44. [cited by applicant]
EBI, PA No. CP004800.2. [cited by applicant]
Edgar, Muscle: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. Mar. 19, 2004;32(5):1792-7. [cited by applicant]
Finnis et al., High-level production of animal-free recombinant transferrin from [cited by applicant]
Finnis et al., Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem. Feb. 15, 1993;212(1):201-10. [cited by applicant]
Fleer et al., Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y). Oct. 1991;9(10):968-75. [cited by applicant]
Franklin et al., Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med. Feb.-Apr. 2009;30(1-2):86-98. [cited by applicant]
Gasser et al., Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microbial Cell Factories. 2008;7(11):1-18. [cited by applicant]
Gems et al., An autonomously replicating plasmid transforms Aspergillus nidulans at high frequency. Gene. Feb. 1, 1991;98(1):61-7. [cited by applicant]
GenBank Accession No. 1HK3_A, Chain A, Human Serum Albumin Mutant R218p Complexed With Thyroxine (3,3′,5,5′-Tetraiodo-L-Thyronine). 3 pages, Oct. 10, 2012. [cited by applicant]
GenBank Accession No. AAA98797, albumin [ [cited by applicant]
GenBank Accession No. ACF10391, albumin precursor, partial [Capra hircus]. Jul. 26, 2016. 2 pages. [cited by applicant]
GenBank Accession No. AJU45621, Mot2p [ [cited by applicant]
GenBank Accession No. NP_010991, CCR4-NOT core ubiquitin-protein ligase subunit MOT2 [ [cited by applicant]
GenBank ID No. AJU38337, [cited by applicant]
GenBank ID No. AJU42819, [cited by applicant]
GenBank ID No. AJU52240, [cited by applicant]
Grant et al., Glutathione is an essential metabolite required for resistance to oxidative stress in the yeast [cited by applicant]
Grant et al., Glutathione synthetase is dispensable for growth under both normal and oxidative stress conditions in the yeast [cited by applicant]
Guo et al., 3′-end-forming signals of yeast mRNA. Mol Cell Biol. Nov. 1995;15(11):5983-90. [cited by applicant]
Gutiérrez-Escobedo et al., Role of glutathione in the oxidative stress response in the fungal pathogen Candida glabrata. Curr Genet. Aug. 2013;59(3):91-106. [cited by applicant]
Hara et al., Improvement of oxidized glutathione fermentation by thiol redox metabolism engineering in [cited by applicant]
Hatem et al., Glutathione is essential to preserve nuclear function and cell survival under oxidative stress. Free Radic Biol Med. Feb. 2014;67:103-14. [cited by applicant]
Hatem et al., Glutathione is essential to preserve nuclear function and cell survival under oxidative stress. Free Radical Biology and Medicine. 2014;75:S25, Poster P14. [cited by applicant]
Hawksworth et al., Ainsworth & Bisby's Dictionary of The Fungi, Eighth Edition. International Mycological Institute. CAB International, Wallingford. p. 171, (1995). [cited by applicant]
Hoefs, Globulin correction of the albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients. Hepatology. Aug. 1992;16(2):396-403. [cited by applicant]
Irie et al., The yeast MOT2 gene encodes a putative zinc finger protein that serves as a global negative regulator affecting expression of several categories of genes, including mating-pheromone-responsive genes. Mol Ce… [cited by applicant]
Katoh et al., MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. Jan. 20, 2005;33(2):511-8. [cited by applicant]
Katoh et al., MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. Jul. 15, 2002;30(14):3059-66. [cited by applicant]
Katoh et al., Multiple Alignment of DNA Sequences with MAFFT. Bioinformatics for DNA Sequence Analysis, Methods in Molecular Biology. David Posada (Ed.). Humana Press. Chapter 3, pp. 39-64 (2009). [cited by applicant]
Katoh et al., Parallelization of the MAFFT multiple sequence alignment program. Bioinformatics. Aug. 1, 2010;26(15):1899-900. [cited by applicant]
Katoh et al., PartTree: an algorithm to build an approximate tree from a large No. of unaligned sequences. Bioinformatics. Feb. 1, 2007;23(3):372-4. [cited by applicant]
Kelly et al., [cited by applicant]
Kerry-Williams et al., Disruption of the [cited by applicant]
Kistler et al., Genetic and biochemical analysis of glutathione-deficient mutants of [cited by applicant]
Kjeldsen et al., Secretory expression of human albumin domains in [cited by applicant]
Kobayashi et al., The development of recombinant human serum albumin. Ther Apher. Nov. 1998;2(4):257-62. [cited by applicant]
Kragh-Hansen et al., Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. Jun. 2002;25(6):695-704. [cited by applicant]
Kren et al., In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med. Mar. 1998;4(3):285-90. [cited by applicant]
Kruk et al., The multifunctional Ccr4-Not complex directly promotes transcription elongation. Genes Dev. Mar. 15, 2011;25(6):581-93. [cited by applicant]
Lee et al., The essential and ancillary role of glutathione in [cited by applicant]
Lodi et al., Secretion of human serum albumin by Kluyveromyces lactis overexpressing KIPDI1 and KIERO1. Appl Environ Microbiol. Aug. 2005;71(8):4359-63. [cited by applicant]
Lowman et al., Selecting high-affinity binding proteins by monovalent phage display. Biochemistry. Nov. 12, 1991;30(45):10832-8. [cited by applicant]
Maris et al., Glutathione, but not transcription factor Yap1, is required for carbon source-dependent resistance to oxidative stress in [cited by applicant]
Mazzoni et al., The inactivation of KINOT4, a Kluyveromyces lactis gene encoding a component of the CCR4-NOT complex, reveals new regulatory functions. Genetics. Jul. 2005;170(3):1023-32. [cited by applicant]
Miller et al., Ccr4-Not complex: the control freak of eukaryotic cells. Crit Rev Biochem Mol Biol. Jul.-Aug. 2012;47(4):315-33. [cited by applicant]
Minghetti et al., Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. May 25, 1986;261(15):6747-57. [cited by applicant]
Mortimer et al., Genealogy of principal strains of the yeast genetic stock center. Genetics. May 1986;113(1):35-43. [cited by applicant]
Murray et al., Unexpected divergence and molecular coevolution in yeast plasmids. J Mol Biol. Apr. 5, 1988;200(3):601-7. [cited by applicant]
Nardi et al., Assay of gamma-glutamylcysteine synthetase and glutathione synthetase in erythrocytes by high-performance liquid chromatography with fluorimetric detection. J Chromatogr. Aug. 24, 1990;530(1):122-8. [cited by applicant]
NCBI Accession No. XP_517233, Predicted: serum albumin [Pan troglodytes]. Jun. 2, 2016. 2 pages. [cited by applicant]
Needleman et al., A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol. Mar. 1970;48(3):443-53. [cited by applicant]
Neilsen et al., Production of biopharmaceutical proteins by yeast. Jul./Aug. 2013. Bioengineered. vol. 4, No. 4, p. 207-211. [cited by applicant]
Ner et al., A simple and efficient procedure for generating random point mutations and for codon replacements using mixed oligodeoxynucleotides. DNA. Mar. 1988;7(2):127-34. [cited by applicant]
Ness et al., DNA shuffling of subgenomic sequences of subtilisin. Nat Biotechnol. Sep. 1999;17(9):893-6. [cited by applicant]
Ohtake et al., Molecular cloning of the gamma-glutamylcysteine synthetase gene of [cited by applicant]
Painting et al., A note on the presence of novel DNA species in the spoilage yeasts [cited by applicant]
Penninckx, A short review on the role of glutathione in the response of yeasts to nutritional, environmental, and oxidative stresses. Enzyme Microb Technol. Jun. 1, 2000;26(9-10):737-742. [cited by applicant]
Preissler et al., Not4-dependent translational repression is important for cellular protein homeostasis in yeast. EMBO J. Jul. 14, 2015;34(14):1905-24. [cited by applicant]
Pócsi et al., Glutathione, altruistic metabolite in fungi. Adv Microb Physiol. 2004;49:1-76. [cited by applicant]
Reidhaar-Olson et al., Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences. Science. Jul. 1, 1988;241(4861):53-7. [cited by applicant]
Rice et al., EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. Jun. 2000;16(6):276-7. [cited by applicant]
Romanos et al., Foreign gene expression in yeast: a review. Yeast. Jun. 1992;8(6):423-88. [cited by applicant]
Scherer et al., Replacement of chromosome segments with altered DNA sequences constructed in vitro. Proc Natl Acad Sci U S A. Oct. 1979;76(10):4951-5. [cited by applicant]
Skinner et al., Biology and Activities of Yeasts. Academic Press, London. Table of Contents. 7 pages (1980). [cited by applicant]
Sleep et al., Albumin and its application in drug delivery. Expert Opin Drug Deliv. May 2015;12(5):793-812. [cited by applicant]
Sleep et al., The secretion of human serum albumin from the yeast [cited by applicant]
Spector et al., A genetic investigation of the essential role of glutathione: mutations in the proline biosynthesis pathway are the only suppressors of glutathione auxotrophy in yeast. J Biol Chem. Mar. 9, 2001;276(10):… [cited by applicant]
Storici et al., In vivo site-directed mutagenesis using oligonucleotides. Nat. Biotechnol. Aug. 2001;19(8):773-6. [cited by applicant]
Tang et al., Three-pathway combination for glutathione biosynthesis in [cited by applicant]
Thompson et al., CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. Nov. 11, 1994;22(… [cited by applicant]
Tian et al., Accurate multiplex gene synthesis from programmable DNA microchips. Nature. Dec. 23, 2004;432(7020):1050-4. [cited by applicant]
UniProtKB—P02768 (Albu_Human). 31 pages. Apr. 25, 2018. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. O35090, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 6 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P02768, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 57 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P02769, RecName: Full=Serum albumin; Flags; Full=BSA; AltName: Allergen=Bos d 6; Flags: Precursor. Nov. 2, 2016. 13 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P02770, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 8 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P07724, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 10 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P08835, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 6 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P14639, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 10 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P19121, RecName: Full=Serum albumin; AltName: Full=Alpha-livetin; AltName: Allergen=Gal d 5; Flags: Precursor. Nov. 2, 2016. 5 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P35747, RecName: Full=Serum albumin; AltName: Allergen=Equ c 3; Flags: Precursor. Nov. 2, 2016. 10 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P49064. RecName: Full=Serum albumin; AltName: Allergen=Fel d 2; Flags: Precursor. Nov. 2, 2016. 7 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P49065, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 10 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. P49822, RecName: Full=Serum albumin; AltName: Allergen=Can f 3; Flags: Precursor. Nov. 2, 2016. 7 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. Q28522, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2016. 6 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. Q5XLE4, RecName: Full=Serum albumin; Flags: Precursor. Nov. 2, 2006. 6 pages. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. Q6WDN9, Preproalbumin precursor. Nov. 28, 2006. 1 page. [cited by applicant]
UniProtKB/Swiss-Prot Accession No. Q95VB7, Albumin. Oct. 31, 2006. 1 page. [cited by applicant]
Valkonen et al., Effects of inactivation and constitutive expression of unfolded-protein response pathway on protein production in the yeast [cited by applicant]
Volkert et al., Deoxyribonucleic acid plasmids in yeasts. Microbiol Rev. Sep. 1989;53(3):299-317. [cited by applicant]
Volohonsky et al., A spectrophotometric assay of gamma-glutamylcysteine synthetase and glutathione synthetase in crude extracts from tissues and cultured mammalian cells. Chem Biol Interact. Apr. 20, 2002;140(1):49-65. [cited by applicant]
Watanabe et al., Purification and Characterization of gamma-Glutamylcysteine Synthetase of [cited by applicant]
Wheeler et al., Glutathione regulates the expression of gamma-glutamylcysteine synthetase via the Met4 transcription factor. Molecular Microbiology. 2002;2:545-556. [cited by applicant]
WPI, Accession No. 2012-A72980, New delta-gamma-glutamylcyssteine synthetase 1 (gsh1) deletion mutant strain of [cited by applicant]
Xu et al., Effects of GSH1 and GSH2 Gene Mutation on Glutathione Synthetases Activity of [cited by applicant]
Yamaguchi et al., Homology modeling and structural analysis of human gamma-glutamylcysteine ligase catalytic subunit for antitumor drug development. Journal of Biophysical Chemistry. 2012;3(3):238-248. [cited by applicant]
Yang et al., Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. Biochem Pharmacol. Jul. 15, 2007;74(2):372-81. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/EP2018/066344, dated Jul. 30, 2018, 14 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2016/068239, dated Mar. 10, 2017, 12 pages. [cited by applicant]
U.S. Appl. No. 15/593,549, filed May 12, 2017, 2018-0009856, Abandoned. [cited by applicant]
U.S. Appl. No. 15/677,164, filed Aug. 15, 2017, U.S. Pat. No. 10,023,618, Issued. [cited by applicant]
U.S. Appl. No. 16/624,616, filed Dec. 19, 2019, U.S. Pat. No. 11,130,979, Issued. [cited by applicant]
U.S. Appl. No. 14/464,991, filed Sep. 2, 2021, U.S. Pat. No. 11,396,670, Issued. [cited by applicant]
Collart, The Ccr4-Not complex is a key regulator of eukaryotic gene expression. Wiley Interdiscip Rev RNA. Jul. 2016;7(4):438-54. [cited by applicant]
Darby et al., Which yeast species shall I choose? [cited by applicant]
Mulder et al., DNA damage and replication stress induced transcription of RNR genes is dependent on the Ccr4-Not complex. Nucleic Acids Res. Nov. 7, 2005;33(19):6384-92. [cited by applicant]
Tran et al., Pichia pastoris versus [cited by applicant]
Albumin Bioscience, Our Products. Retrieved online at: https://www.albuminbio.com/our-products/. 10 pages, Mar. 23, 2024. [cited by applicant]
Albumin Bioscience, Recombinant Mouse Serum Albumin. Retrieved online at: https://www.albuminbio.com/our-shop/recombinant-mouse-albumin/recombinant-mouse-serum-albumin/. 4 pages, Mar. 23, 2024. [cited by applicant]
Albumin Bioscience, Recombinant Rabbit Albumin. Retrieved online at: https://www.albuminbio.com/our-shop/recombinant-rabbit-albumin/recombinant-rabbit-albumin/. 3 pages, Mar. 23, 2024. [cited by applicant]
Albumin Bioscience, Recombinant Rat Albumin. Retrieved online at: https://www.albuminbio.com/our-shop/recombinant-rat-albumin/recombinant-rat-albumin/. 3 pages, Mar. 23, 2024. [cited by applicant]
Andersen et al., Single-chain variable fragment albumin fusions bind the neonatal Fc receptor (FcRn) in a species-dependent manner: implications for in vivo half-life evaluation of albumin fusion therapeutics. J Biol Ch… [cited by applicant]
Borstein et al., Yeast: an experimental organism for 21st Century biology. Genetics. Nov. 2011;189(3):695-704. [cited by applicant]
Kim et al., Yeast synthetic biology for the production of recombinant therapeutic proteins. FEMS Yeast Res. Feb. 2015;15(1):1-16. [cited by applicant]
Liu et al., Principles of genetic engineering and experimental guidance. Professional textbooks for colleges and Universities. China Light Industry Press. pp. 114-117, (2010). [cited by applicant]